Literature DB >> 1769931

Biotype and antibiotic sensitivity of 100 clinical isolates of Yersinia enterocolitica.

J N Pham1, S M Bell, J Y Lanzarone.   

Abstract

One hundred clinical isolates of Yersinia enterocolitica were biotyped, serotyped and tested for in-vitro sensitivity to seven beta-lactam antibiotics and six other antibiotics. Twenty-four of the isolates belonged to Niléhn's and Wauters' biotype 1A, 12 to biotype 3 and 64 to biotype 4. No biotypes 1B or 2 strains were found. All isolates were sensitive to chloramphenicol, ciprofloxacin, gentamicin, tetracycline, trimethoprim and all but one to sulphafurazole. All were resistant to ampicillin with MIC's ranging from 32 to 256 mg/L, but were susceptible to ticarcillin/clavulanic acid and imipenem. With other beta-lactam agents there were different patterns of sensitivity, specific to each of the three biotypes. All biotype 4 strains were resistant to carbenicillin and ticarcillin but sensitive to amoxycillin/clavulanic acid and cefoxitin. Biotype 3 strains, by contrast, were sensitive to carbenicillin and ticarcillin but resistant to amoxycillin/clavulanic acid and cefoxitin, whilst biotype 1A strains were resistant to each of these four beta-lactam agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769931     DOI: 10.1093/jac/28.1.13

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Characterization of the interaction between Yersinia enterocolitica biotype 1A and phagocytes and epithelial cells in vitro.

Authors:  T Grant; V Bennett-Wood; R M Robins-Browne
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Characterisation of atypical biotype 3, serotype O:3 Yersinia and development of a simple identification scheme.

Authors:  J N Pham; S M Bell; I Guilvout; L Martin; E Carniel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

3.  Identification of virulence-associated characteristics in clinical isolates of Yersinia enterocolitica lacking classical virulence markers.

Authors:  T Grant; V Bennett-Wood; R M Robins-Browne
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 4.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

5.  Bacterial pathogens associated with diarrhoea on the island of Crete.

Authors:  G Samonis; S Maraki; A Christidou; A Georgiladakis; Y Tselentis
Journal:  Eur J Epidemiol       Date:  1997-10       Impact factor: 8.082

6.  Bacterial colitis.

Authors:  Harry T Papaconstantinou; J Scott Thomas
Journal:  Clin Colon Rectal Surg       Date:  2007-02

7.  Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990.

Authors:  M A Preston; S Brown; A A Borczyk; G Riley; C Krishnan
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 8.  Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review.

Authors:  Fataneh Hashempour-Baltork; Hedayat Hosseini; Saeedeh Shojaee-Aliabadi; Mohammadali Torbati; Adel Mirza Alizadeh; Matin Alizadeh
Journal:  Adv Pharm Bull       Date:  2019-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.